IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
复制标题
DOI:
10.3410/f.1023760.282705
复制
发表时间:
2004
期刊:
影响因子:
64.5
通讯作者:
D. Cai;J. Frantz;N. Tawa;P. A. Meléndez;Byung-Chul Oh;H. Lidov;P. Hasselgren;W. Frontera;
中科院分区:
文献类型:
--
作者:
D. Cai;J. Frantz;N. Tawa;P. A. Meléndez;Byung-Chul Oh;H. Lidov;P. Hasselgren;W. Frontera;
Muscle wasting accompanies aging and pathological conditions ranging from cancer, cachexia, and diabetes to denervation and immobilization. We show that activation of NF-kappaB, through muscle-specific transgenic expression of activated IkappaB kinase beta (MIKK), causes profound muscle wasting that resembles clinical cachexia. In contrast, no overt phenotype was seen upon muscle-specific inhibition of NF-kappaB through expression of IkappaBalpha superrepressor (MISR). Muscle loss was due to accelerated protein breakdown through ubiquitin-dependent proteolysis. Expression of the E3 ligase MuRF1, a mediator of muscle atrophy, was increased in MIKK mice. Pharmacological or genetic inhibition of the IKKbeta/NF-kappaB/MuRF1 pathway reversed muscle atrophy. Denervation- and tumor-induced muscle loss were substantially reduced and survival rates improved by NF-kappaB inhibition in MISR mice, consistent with a critical role for NF-kappaB in the pathology of muscle wasting and establishing it as an important clinical target for the treatment of muscle atrophy.